vimarsana.com
Home
Live Updates
Albireo to Showcase New Data at AASLD The Liver Meeting®
Albireo to Showcase New Data at AASLD The Liver Meeting®
Albireo to Showcase New Data at AASLD The Liver Meeting®
– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable efficacy in patients...
Related Keywords
United States ,
Germany ,
United Kingdom ,
Massachusetts ,
Washington ,
Belgium ,
Gothenburg ,
Vastra Gotalands Lan ,
Sweden ,
Italy ,
Boston ,
Austria ,
Spain ,
Northern Ireland ,
Craigavon ,
London ,
City Of ,
Scotland ,
Henkjanj Verkade ,
Colleen Alabiso ,
Lorenzo Dantiga ,
Lance Buckley ,
Richardj Thompson ,
Franciscoj Caballero Camino ,
Intrahepatic Cholestasis ,
Azienda Ospedaliera Papa Giovanni ,
Georg Friedrich Vogel ,
King College London ,
Albireo Pharma Inc ,
Department Of Paediatric Hepatology ,
University Of Innsbruck ,
Department Of Paediatrics ,
European Commission ,
Institute Of Liver ,
Nasdaq ,
Exchange Commission ,
Beatrix Children Hospital University Medical Centre Groningen ,
Astrazeneca ,
Healthcare Products Regulatory Agency ,
University Of Groningen ,
Access Program ,
American Association ,
Liver Diseases ,
Native Liver Survival ,
Progressive Familial Intrahepatic ,
Liver Studies ,
Pediatric Liver ,
Pooled Data ,
Beatrix Children ,
University Medical Centre Groningen ,
Poster Session ,
Long Term Efficacy ,
Progressive Familial Intrahepatic Cholestasis ,
College London ,
Odevixibat Treatment ,
Recurrent Episodic Cholestasis ,
Biallelic Mutations ,
Retrospective Case ,
Angelo Di Giorgio ,
Hospital Papa Giovanni ,
Odevixibat Therapy ,
Assistant Professor ,
Medical University ,
Innsbruck ,
Serum Bile Acid Levels ,
Pruritus Scores ,
Growth Over Time ,
Odevixibat Responders ,
Lorenzod Antiga ,
Paediatric Hepatology ,
Urinary Excretion ,
Bile Acids ,
Halts Liver Disease Progression ,
Obstructed Mice ,
Instituto De Investigaci ,
Sanitaria Biodonostia ,
San Sebasti ,
Basque Country ,
United Kingdom Medicines ,
Test Abnormalities ,
Soluble Vitamin ,
Open Label Extension ,
Private Securities Litigation Reform Act ,
Expanded Access Program ,
Annual Report ,
Nasdaq Albo ,
Albireo Pharma ,
Nc ,